MAPT and Cognitive impairment: Cross-sectional tau PET studies examining in vivo tau deposition in clinically unimpaired (CU) individuals, those with mild cognitive impairment (MCI), and those with AD have largely confirmed these postmortem observations and have provided additional insights regarding patterns in cortex.